Amundi Boosts Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Amundi grew its holdings in Oscar Health, Inc. (NYSE:OSCR) by 232.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 690,654 shares of the company’s stock after buying an additional 482,784 shares during the quarter. Amundi owned 0.28% of Oscar Health worth $9,282,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. KBC Group NV increased its position in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock valued at $96,000 after buying an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at approximately $100,000. Alberta Investment Management Corp purchased a new stake in shares of Oscar Health during the fourth quarter worth approximately $138,000. SMART Wealth LLC purchased a new stake in shares of Oscar Health during the fourth quarter worth approximately $180,000. Finally, Tempus Wealth Planning LLC purchased a new stake in shares of Oscar Health during the fourth quarter worth approximately $181,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Up 2.7 %

Shares of NYSE:OSCR opened at $13.23 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The business has a fifty day moving average of $15.21 and a two-hundred day moving average of $16.39. The stock has a market cap of $3.31 billion, a P/E ratio of -660.92 and a beta of 1.75. Oscar Health, Inc. has a 52-week low of $12.43 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Analysts Set New Price Targets

OSCR has been the subject of several research reports. Wells Fargo & Company cut Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $20.00 to $16.00 in a research report on Thursday. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company. Two research analysts have rated the stock with a sell rating, three have given a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Oscar Health presently has an average rating of “Hold” and a consensus target price of $20.19.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.